Erica Yim

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Analysis Group (United States)(Current)

Teva Pharmaceuticals (United States)

Teva Pharmaceuticals (Netherlands)

Erica Yim is an author at Analysis Group (United States) specializing in headache management, real-world comparative effectiveness, and preventive migraine treatment.

Publications per year

2022–2024

Publications

Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine

Maurice T. Driessen, Joshua M. Cohen, Stephen F. Thompson et al. · The Journal of Headache and Pain · 2022 · 44 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study

Maurice T. Driessen, Joshua M. Cohen, Oscar Patterson‐Lomba et al. · The Journal of Headache and Pain · 2022 · 22 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials

Craig M. McDonald, James Signorovitch, Eugenio Mercuri et al. · PLoS ONE · 2024 · 13 citations · Full text

Medicine, Rehabilitation Medicine, Motor Development +16

1–3 of 3